Acorda TherapeuticsACORQ
13F holders, Q1 2024 (March 31)17holders
1famous investor
$12.82avg. 13F price*
At the end of Q1 2024, 17 institutions reported holding Acorda Therapeutics Inc. (ACORQ) in their 13F filings. The largest holders were Davidson Kempner Capital Management LP ($689K), Renaissance Technologies ($618K) and Acadian Asset Management LLC ($420K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Acorda Therapeutics Inc.
- CUSIP
- 00484M700
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $1K |
| Exits | 0 | $0 |
Ownership 17 holders
| Davidson Kempner Capital Management LP | 0.01% | No change | 55,145 | $689K |
| Renaissance Technologies | 0.00% | Add +2.2% | 46,761 | $618K |
| Acadian Asset Management LLC | 0.00% | No change | 33,691 | $420K |
| Vanguard Group Inc. | 0.00% | Add +78.2% | 19,260 | $254K |
| BlackRock Inc. | 0.00% | Reduce -7.9% | 6,107 | $81K |
| Wells Fargo & Company | 0.00% | Reduce -0.1% | 3,736 | $49K |
| Morgan Stanley | 0.00% | Reduce -3.3% | 1,137 | $15K |
| Russell Investments Group, Ltd. | 0.00% | No change | 300 | $4K |
| UBS Group AG | 0.00% | Reduce -64.4% | 106 | $1K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 103 | $1K |
| Bank of America Corp. | 0.00% | Add +2.0% | 51 | $674 |
| FMR LLC | 0.00% | New | 9 | $114 |
| JPMorgan Chase & Co. | 0.00% | Add +33.3% | 4 | $50 |
| First Manhattan Co. Llc. | 0.00% | No change | 3 | $39 |
| Osaic Holdings, Inc. | 0.00% | No change | 1 | $13 |
| Qube Research & Technologies Ltd | 0.00% | No change | 1 | $13 |
| Royal Bank of Canada | 0.00% | No change | 14 | $0 |
"% of holder's portfolio" is ACORQ's weight in each manager's 13F, not the share of Acorda Therapeutics Inc. the manager owns.